Physicians Committee for Responsible Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Physicians Committee for Responsible Medicine sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).
Physicians Committee for Responsible Medicine: 26 sponsored US clinical trials, 4 recruiting.
Physicians Committee for Responsible Medicine sponsors 26 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 22 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 3 trials.
Top-decile sponsor footprint
Physicians Committee for Responsible Medicine ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
22 of 22 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
26 total, page 1 of 1
Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools
NCT07595562
Diabetes Reversal Online Program and Study (DROP Study)
NCT05572502
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
NCT05795439
Nutritional Intervention for Endometriosis
NCT05175248
The Effect of a Low-fat Vegan Dietary Intervention on Intracellular Lipid, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes
NCT06106035
Effect of a Dietary Intervention on Insulin Requirements in Type 1 Diabetes
NCT04944316
Womens Study to Alleviate Vasomotor Symptoms
NCT04587154
Hospital Workplace Nutrition Study
NCT04222894
Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight
NCT03698955
Effect of Dietary Cholesterol on Plasma Lipids
NCT03698929
A Nutrition Intervention for Arthritis -4 (WCCR-ARTH4)
NCT03580681
A Nutrition Intervention for Arthritis -3 (WCCR-ARTH3)
NCT03417648
Diet, Insulin Sensitivity, and Postprandial Metabolism
NCT02939638
Practice Based Nutrition Intervention-2
NCT01700868
A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)
NCT01953757
A Nutritional Intervention for Diabetic Neuropathy
NCT01690962
A Nutrition Intervention for Arthritis -2
NCT01700881
A Nutritional Intervention for Migraines-2
NCT01699009
A Nutritional Intervention for Migraines
NCT01547494
A Nutritional Intervention for Arthritis
NCT01544101
Multicenter Worksite Nutrition Study
NCT01224548
Plant-based Dietary Intervention for Treatment of Acne
NCT00900939
Development and Validation of the Food Acceptability Questionnaire
NCT00412724
Worksite Nutrition Study
NCT00481897
Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
NCT00360919
Plant-Based Dietary Intervention in Type 2 Diabetes
NCT00276939
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Physicians Committee for Responsible Medicine pipeline
4 recruiting of 26 indexed (15% open); 22 completed (85%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (3 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Physicians Committee for Responsible Medicine: open-pipeline peers nationwide
Peers matched on 26 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Physicians Committee for Responsible Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 26 trials (± recruiting share)
- Abbott Diabetes Care · 26 trials · 12% recruiting
- Aldeyra Therapeutics · 26 trials · 4% recruiting
- California Polytechnic State University-San Luis Obispo · 26 trials · 19% recruiting
- DexCom · 26 trials · 4% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this Physicians Committee for Responsible Medicine page
26 registered trials is a research-attention snapshot, not an endorsement of Physicians Committee for Responsible Medicine or any single study.
- 4 of Physicians Committee for Responsible Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Physicians Committee for Responsible Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Physicians Committee for Responsible Medicine pipeline card: 26 registered trials from official public datasets.Report a data error.